Dartmouth Integrative Biology Symposium Invited Speakers
Julie Makani, Ph.D., is a Wellcome Trust Research Fellow and Senior lecturer in Haematology and Blood Transfusion at Muhimbili University of Health and Allied Sciences (MUHAS). She trained in Medicine (Tanzania) and Internal Medicine (UK), and completed her PhD in clinical epidemiology of sickle cell disease (SCD). In 2004, she received a Wellcome Trust training fellowship and established the SCD programme at MUHAS, with prospective surveillance of over 3,000 SCD patients. Working with colleagues, they have developed a biomedical research and healthcare programme (http://www.muhimbili-wellcome.org/, which is one of the largest SCD cohorts from one centre in the world. She is a consultant physician at Muhimbili National Hospital and clinical research fellow in the Nuffield department of clinical medicine, Oxford University. She received the 2011 Royal Society Pfizer Award for her work in using anaemia in SCD as a model of translating genetic research into health benefit. In 2012 she was elected a Fellow of Tanzania Academy of Sciences and in 2013, Fellow of Royal College of Physicians of United Kingdom. She is working with colleagues to establish networks at national, regional [Sickle Cell Disease Research Network of East and Central Africa (REDAC)] and global level, Global SCD Research Network (http://www.globalsicklecelldisease.org).
Timothy R. Rebbeck, Ph.D., is Professor of Epidemiology, Director of the Center for Genetics and Complex Traits and Associate Director for Population Science in the Abramson Cancer Center at the University of Pennsylvania. The goal of Dr. Rebbeck's research is to understand the complex causes of cancer. He uses a multidisciplinary approach to identify and characterize genes and other biomarkers associated with human cancer, and to determine how these biological factors interact with environmental exposures in the etiology and progression of cancer. His work focuses on cancers of the breast, ovary, and prostate, with a particular emphasis on global health disparities. He leads multiple international research consortia that leverage the diversity of global populations to better inform the etiology and prevention of common cancers worldwide.
Sarah Tishkoff, Ph.D., is the David and Lyn Silfen University Professor in Genetics and Biology at the University of Pennsylvania, holding appointments in the School of Medicine and the School of Arts and Sciences. Dr. Tishkoff studies genomic and phenotypic variation in ethnically diverse Africans. Her research combines field work, laboratory research, and computational methods to examine African population history and how genetic variation can affect a wide range of practical issues – for example, why humans have different susceptibility to disease, how they metabolize drugs, and how they adapt through evolution. Dr. Tishkoff is a recipient of an NIH Pioneer Award, a David and Lucile Packard Career Award, a Burroughs/Wellcome Fund Career Award and a Penn Integrates Knowledge (PIK) endowed chair. She is on the editorial boards at Genome Research; Evolution, Medicine, and Public Health; Molecular Biology and Evolution; G3 (Genes, Genomes, and Genetics).
Sten Vermund, M.D., Ph.D., has been conducting clinical and public health research since 1982. He is known first for his pioneering work in the relationship between HIV and human papillomavirus, illuminating the association and increased cervical disease risk in the late 1980s and co-developing major cervical cancer screening programs nested within PEPFAR programs in Africa in the 2000s. Second is his HIV prevention and clinical research domestically and internationally, initially as a pediatrician with special interests in adolescent medicine and prevention of mother-to-child transmission, and also in issues of women's reproductive health. Third are his contributions in forging the field of global health and his innovations in HIV training and educational evaluation. He has founded numerous global health research and service entities, particularly focusing on Zambia, Mozambique, Nigeria, Peru, and Jamaica, and he has worked in training and capacity building supporting more than 500 trainees from over two dozen countries. Dr. Vermund was awarded the Superior Service Award of the U.S. Public Health Service, its highest civilian award, and his contributions in infectious disease epidemiology, women's and children's health, and global health are presented in over 340 peer reviewed articles and 100 book chapters and other publications.